Acorah Software Products - Accounts Production 16.0.110 false true false true No description of principal activity 30 March 2023 30 June 2024 30 June 2024 14769333 Mr Oliver White iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14769333 2023-03-29 14769333 2024-06-30 14769333 2023-03-30 2024-06-30 14769333 frs-core:CurrentFinancialInstruments 2024-06-30 14769333 frs-bus:PrivateLimitedCompanyLtd 2023-03-30 2024-06-30 14769333 frs-bus:FilletedAccounts 2023-03-30 2024-06-30 14769333 frs-bus:Micro-entities 2023-03-30 2024-06-30 14769333 frs-bus:AuditExempt-NoAccountantsReport 2023-03-30 2024-06-30 14769333 frs-bus:Director1 2023-03-30 2024-06-30
Registered number: 14769333
Unique Nootropics Ltd
Unaudited Financial Statements
For the Period 30 March 2023 to 30 June 2024
TaxAssist Accountants
64 Southwark Bridge Road
London
SE1 0AS
Balance Sheet
Registered number: 14769333
30 June 2024
£
Current assets 9,103
Creditors: Amounts Falling Due Within One Year (14,996 )
NET CURRENT LIABILITIES (5,893 )
TOTAL ASSETS LESS CURRENT LIABILITIES (5,893 )
Accruals and deferred income (885 )
NET LIABILITIES (6,778 )
CAPITAL AND RESERVES (6,778 )

Notes

1. General Information
Unique Nootropics Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14769333 . The registered office is 64 Southwark Bridge Road, London, England, SE1 0AS.
2. Average Number of Employees
Average number of employees, including directors, during the year was as follows: 1
1
For the period ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Oliver White
Director
18 November 2024